Business and People Update April 2008


Applied Clinical Trials

Applied Clinical TrialsApplied Clinical Trials-04-01-2008
Volume 0
Issue 0

A look at the latest industry news


• Good Products (Nottingham, UK) recently welcomed two new staff members to the company: Patrick Hughes will be based in Irvine, CA, and spearhead North American activities as senior vice president of strategic development, and Dr. Neil Rotherham will work out of the company's headquarters as executive chairman.

Patrick Hughes

Dr. Neil Rotherham

• Vincent Renz accepted the position of ClinPhone's (Nottingham, UK) chief operating officer. Additionally, Paula McHale takes on the role of director of product management, data management solutions.

Vincent Renz

Dr. Satish Tripathi

• Satish Tripathi, PhD, is Kendle's (Cincinnati, OH) new vice president of global regulatory and quality.

• As Praxis' (Brentwood, TN) director of business development, Richard Chin will manage business development activities for the company's West coast clients.

  • Three new hires have joined Cetero Research (Cary, NC). Dr. Robert Cooper and Dr. Gregory Haugen are now principal investigators at the company's facility in Fargo, ND, and Dr. Ramon Vargas is the new medical director at the company's St. Charles, MO, branch.

  • Donna Hasslinger will serve as the Drug Information Association's (Horsham, PA) new worldwide director of member and volunteer services.

  • DecisionView (San Francisco, CA) selected Gonzalo Castro as vice president of product marketing.

  • James Farley,Cardinal Consulting and Training's (Savannah, GA) president, has taken on an advisory role for InfoStrength (Durham, NC).

  • D. Anderson & Company (Dallas, TX) announced that Senior Project Manager Susan Warne will serve a two-year term on the Board of Trustees for the Association of Clinical Research Professionals (Washington, DC). Additionally, Dr. Diana Anderson, D. Anderson's president and chief executive officer, will serve as chairman of the Board of the Academy of Clinical Research Professionals (Washington, DC) for the third year running.

  • Ronald Norton is heading up AAIPharma's (Wilmington, NC) expanded North American Exploratory Development Services as the company's new vice president of exploratory development.


  • InferMed (London, UK) collaborated with Siemens (Munich, Germany) and researchers at the Technical University of Munich to establish a method that allows the automatic transference of electronic medical record data to InferMed's EDC solution, MACRO.

  • Image Solutions (ISI; Philadelphia, PA) teamed up with EMC (Hopkinton, MA) to sell Compliance-in-a-Box Submission Edition, which combines ISI's regulatory suite and EMC's Enterprise Content Management solutions to make it easier for companies to comply with the FDA's 2008 eCTD guidance.

  • Ketchum (New York, NY) is broadening its range of services now that subject recruitment agency MMG (Rockville, MD) will be operating as a distinct business unit within the Ketchum network.

  • Definiens (Munich, Germany) will provide Montpellier Rio Imaging (Montpellier, France) with technology for image analysis and data management.

  • Tokyo, Japan-based Astellas Pharma will continue to have access to MorphoSys' (Munich, Germany) HuCAL GOLD, the company's proprietary antibody library, after the two companies decided to extend an agreement first established in March 2007. The newly expanded collaboration will expire in March of 2012.

  • Catalent Pharma Solutions (Somerset, NJ) will provide a client with Isopak's (Lincolnshire, UK) Minicap 100 semiautomatic capsule filling device for an upcoming trial.

  • Pleiad Devices (Cambridge, MA) decided to use OmniComm Systems' (Fort Lauderdale, FL) EDC solution, TrialMaster.

  • Microsoft (Redmond, WA) announced a partnership with SAP America (Newtown Square, PA) at the Healthcare Information and Management Systems Society 2008 Conference & Exhibition in Orlando, FL. The companies will work together to provide the health care industry with software solutions aimed at increasing efficiency, streamlining processes, and cutting costs.

Company News

  • LCG Bioscience (Cambridge, UK) announced that the company has proudly adopted the requirements to prepare for the Medicines and Healthcare Products Regulatory Agency's (London, UK) Accreditation Scheme, which is directed at Phase I arenas in the UK and meant to help restore public faith in clinical trials after the TGN1412 incident. The Accreditation Scheme will provide formal guidance on conducting first-in-man trials of molecules involving unknown risk levels.

  • MDS Pharma Services' (King of Prussia, PA) Global Central Lab launched Apollo, a new Web-based study management system designed to securely track study samples and results in real-time.

  • Octagon Research Solutions (Wayne, PA) announced that StartingPoint 3.0, the company's newest version of its suite of submission document authorizing templates, is now on the market. It offers additional content templates, a document validation button to pinpoint invalidities, document information for field codes, and more.

  • The Drug Information Association's (Horsham, PA) Annual EuroMeeting in Barcelona, Spain, last month saw the introduction of Almac Clinical Technologies' (Yardley, PA) expanded Express Suite, which now includes the company's iTrial EDC solution.

  • MedPoint Communications (Evanston, IL) created a new subsidiary company called Qicme, which will center around quality improvement.

  • Those interested in cardiovascular science and research can now access a digital archive of more than 2700 oral presentations delivered at the American Heart Association's (Dallas, TX) 2007 Annual Scientific Sessions conference, which took place November 4–7, courtesy of Conference Archives' (Johnstown, PA) Sessions Science OnDemand.

  • Aris Global (Stamford, CT) is offering two new comprehensive clinical trials management solutions—agClinical and agClinical NW—that can track clinical trial activities while ensuring ICH GCP compliance.

  • i3 Innovus (Waltham, MA) plans to launch integrated, customizable late phase research services. Senior Vice President Cynthia Verst will lead the late phase research group.

  • Tepnel (Manchester, UK) released a range of biopharmaceutical testing services for discovery, preclinical, and clinical drug development, as well as postmarketing support.


  • Quotient BioResearch (Newmarket, UK) boosts its drug development capabilities with the acquisition of BioDynamics Research (Northamptonshire, UK). BioDynamics is the fourth company purchased by Quotient since its establishment in 2007.

  • Chiltern (London, UK) acquired Drug Development Solutions, a 42-bed Phase I facility in Dundee, Scotland's Ninewells Hospital and Medical School.

  • Azopharma Product Development Group (Miramar, FL) bought bio-analytical laboratory Analytical Development Corporation (Colorado Springs, CO). The lab will now function under the ADMEquant Bioanalytical Services name.

  • Dublin, Ireland-based Icon extends the reach of its early phase services into the United States with the purchase of Healthcare Discoveries (San Antonio, TX), an 85-bed pharmacology facility and subsidiary of Catalyst Pharma Group (Pasadena, CA). Icon initially paid $12 million, and if specific milestones are reached this year, the company may pay an added maximum of $10 million.

  • Dara BioSciences (Raleigh, NC) officially completed a merger with Point Therapeutics (Wellesley Hills, MA). Under the terms of the agreement, Dara became a wholly owned subsidiary of Point, and Point adopted the name Dara BioSciences.

  • Inverness Medical Innovations (Waltham, MA) finalized its $123.2 million acquisition of BBI Holdings (Cardiff, UK).

  • (Dallas, TX), which provides the health care industry with electronic transaction services, aims to add about 35% to its revenue with the acquisition of Acceptius' assets. Acceptius, like, is based in Dallas and provides data processing services.

New Facilities

  • D. Anderson& Company (Dallas, TX) established a new facility in Windsor, UK, in response to an increasing demand for global subject recruitment and retention operations. The Windsor facility will also be utilized as a base for D. Anderson's international vendors and customers.

  • Bilcare Global Clinical Supplies (Phoenixville, PA) created six new, state-of-the-art primary and secondary packaging rooms and upgraded an additional 20 at its 153,000 square foot facility.

  • As part of an $18 million expansion, Metrics (Greenville, NC) is in the process of constructing four new analytical labs, which will nearly double the company's service capacities. Metrics expects the labs to be ready to tackle projects by second quarter this year. The company is also creating spaces for larger scale manufacturing, stability storage, and labs for microbiology and cytotoxic and potent compounds.

  • Azopharma Product Development Group (Miramar, FL) opened a new facility in South Florida to house the company's formulation development services, small-scale manufacturing, and specialized analytical services, as well as ApiCross Drug Delivery Technologies, Azopharma's new drug delivery company.

  • GATC Biotech (Constance, Germany), a DNA sequencing service provider, enhanced its European presence with the addition of a wholly owned subsidiary in Stockholm, Sweden.

  • Phlexglobal (Amersham, UK) announced its expansion into America. The decision was based on increasing demand from U.S.-based clients and potential clients.

  • Magnisense (Paris, France), a diagnostics company, opened new laboratories and offices in Dardilly, France.

  • Lenexa, KS, is the home of PRA International's (Raleigh, NC) new, 80-bed Clinical Pharmacology Center.

  • World Care Clinical relocated its formerly Cambridge, MA-based headquarters to Boston, MA.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.